 |
|
Major Lower Extremity Amputation
Outcome of a Modern Series
Bernadette Aulivola, MD;
Chantel N. Hile, MD;
Allen D. Hamdan, MD;
Malachi G. Sheahan, MD;
Jennifer R. Veraldi, BA;
John J. Skillman, MD;
David R. Campbell, MD;
Sherry D. Scovell, MD;
Frank W. LoGerfo, MD;
Frank B. Pomposelli, Jr, MD
Arch Surg. 2004;139:395-399.
Hypothesis Major lower extremity amputation results in significant morbidity and mortality.
Design Retrospective database query and medical record review for January 1, 1990, to December 31, 2001. Mean follow-up was 33.6 months.
Setting Academic tertiary care center.
Patients Nine hundred fifty-nine consecutive major lower extremity amputations in 788 patients, including 704 below-knee amputations (BKAs) (73.4%) and 255 above-knee amputations (AKAs) (26.6%).
Main Outcome Measures Patient survival, cardiac morbidity, infectious complications, and subsequent operation.
Results Overall 30-day mortality was 8.6%, worse for AKA (16.5%) than BKA (5.7%) patients (P<.001). Thirty-day mortality for guillotine amputation for sepsis control was 14.3% compared with 7.8% for closed amputation (P = .03). Complications included cardiac (10.2%), wound infection (5.5%), and pneumonia (4.5%). Twelve AKA (4.7%) and 129 BKA (18.4%) limbs required subsequent operation. Only 66 BKAs (9.4%) required conversion to AKA (average, 77.1 days postoperatively). Overall survival was 69.7% and 34.7% at 1 and 5 years, respectively. Survival was significantly worse for AKAs (50.6% and 22.5%) than BKAs (74.5% and 37.8%) (P<.001). Survival in patients with diabetes mellitus (DM) was 69.4% and 30.9% vs 70.8% and 51.0% in patients without DM at 1 and 5 years, respectively (P = .002). Survival in end-stage renal disease patients was 51.9% and 14.4% vs 75.4% and 42.2% in patients without renal failure at 1 and 5 years, respectively (P<.001).
Conclusions Major amputation continues to result in significant morbidity and mortality. Survivors with BKA require revision or conversion to AKA infrequently. Long-term survival is dismal for patients with DM and end-stage renal disease and those undergoing AKA.
From the Division of Vascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.
RELATED ARTICLE
This Month in Archives of Surgery
Arch Surg. 2004;139(4):357.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Stepwise Approach to the Surgical Management of Severe Diabetic Foot Infections
Zgonis et al.
Foot & Ankle Specialist 2008;1:46-53.
ABSTRACT
Mortality and preoperative cardiac function in vascular amputees: an N-terminal pro-brain natriuretic peptide (NT-proBNP) pilot study
Riemersma et al.
Clin Rehabil 2008;22:56-59.
ABSTRACT
Negative-Pressure Wound Therapy and Diabetic Foot Amputations: A Retrospective Study of Payer Claims Data
Frykberg and Williams
J. Am. Podiatr. Med. Assoc. 2007;97:351-359.
ABSTRACT
| FULL TEXT
Peripheral Arterial Disease: A Guide for Nephrologists
DeLoach and Mohler
CJASN 2007;2:839-846.
ABSTRACT
| FULL TEXT
Mortality and Hospitalization in Patients After Amputation: A comparison between patients with and without diabetes
Schofield et al.
Diabetes Care 2006;29:2252-2256.
ABSTRACT
| FULL TEXT
|
